Lv61
2106 积分 2024-05-29 加入
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
2小时前
已完结
Pegilodecakin, a Pegylated Human IL-10 (AM0010), Enhances the Cytotoxicity of CAR-T Cells in Vitro and In Vivo
3小时前
已关闭
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
3天前
已完结
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
6天前
已完结
CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study
10天前
已完结
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma
10天前
已完结
CD27-CD45+ γδ T cells can be divided into two populations, CD27-CD45int and CD27-CD45hi with little proliferation potential
12天前
已完结
Engineering innate immune cells for cancer immunotherapy
13天前
已完结
IL-18 revives dysfunctional CAR-T cells
13天前
已完结
Benefit from huCAR19-IL18 cells in patients with CD19(+) lymphomas after CAR T cells
13天前
已关闭
皖公网安备34019202002308
